- HIV ×
-
Why not eliminate HTLV-1 while eliminating HIV-1? We need HTLV-1 PEP/PrEP clinical trials
November 28, 2023
As a former elected member of the Virology Division, it has been my honour to help shape the scientific content of the Annual Conference for the past three years. From close by I have witnessed the amazing science that is done by all members of our Society, the supporting network that is built by and for the members of the Society. Microbes affect us all, the recent Covid pandemic made that very clear to us all. Here, Dr Fabiola Martin and I ask for your support in our call to include a not so well known, yet disabling and often deadly virus, human T-lymphotropic virus-1 (HTLV-1), to be included in HIV-1 pre-exposure clinical trials.
-
HPV in Malawi
September 26, 2017
Malawi, in Sub-Saharan Africa, has the highest incidence and mortality of cervical cancer in the world. Nearly all cases of cervical cancer are caused by human papillomavirus, or HPV.
-
World AIDS Day 2014
December 1, 2014
1 December is World AIDS Day, highlighting the fight against this global pandemic. AIDS, or Acquired Immunodeficiency Syndrome, has killed over 39 million people worldwide since 1981, and some 35 million people are currently estimated to be living with the disease.